Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Biora Therapeutics Q1 2024 GAAP EPS $(0.14) Beats $(0.45) Estimate, Sales $542.000K

Author: Benzinga Newsdesk | May 15, 2024 04:09pm

Biora Therapeutics (NASDAQ:BIOR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.45) by 68.89 percent. This is a 77.78 percent increase over losses of $(0.63) per share from the same period last year. The company reported $542.000 thousand in sales this quarter.

Posted In: BIOR